Conformis, Inc.

$2.27+0.44%(+$0.01)
TickerSpark Score
64/100
Mixed
95
Valuation
35
Profitability
10
Growth
80
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CFMS research report →

52-Week Range20% of range
Low $1.05
Current $2.27
High $7.25

Companywww.conformis.com

Conformis, Inc. , a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products.

CEO
Mark A. Augusti
IPO
2015
Employees
295
HQ
Billerica, MA, US

Price Chart

-66.52% · this period
$6.98$4.04$1.09Sep 14Mar 16Sep 14

Valuation

Market Cap
$17.88M
P/E
-0.32
P/S
0.29
P/B
0.30
EV/EBITDA
0.07
Div Yield
0.00%

Profitability

Gross Margin
37.41%
Op Margin
-74.58%
Net Margin
-81.34%
ROE
-65.24%
ROIC
-56.47%

Growth & Income

Revenue
$62.05M · -37.86%
Net Income
$-50,473,000 · -1991.71%
EPS
$-6.99 · -1841.67%
Op Income
$-46,278,000
FCF YoY
-386.69%

Performance & Tape

52W High
$7.25
52W Low
$1.05
50D MA
$2.23
200D MA
$2.06
Beta
1.42
Avg Volume
156.85K

Get TickerSpark's AI analysis on CFMS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Sep 5, 23Desrochers Christinesell81,465
Sep 5, 23Augusti Mark Aother17,778
Sep 5, 23Augusti Mark Asell190,277
Sep 5, 23BIENKOWSKI CARRIEsell19,909
Sep 5, 23Fischetti Gary Psell10,470
Sep 5, 23Pedulla Denise Esell18,000
Sep 5, 23Langdale Bradleysell18,379
Sep 5, 23JOHNSTON PHILIP Wsell19,273
Sep 5, 23FALLON KENNETH P IIIsell20,320
Jun 12, 23Desrochers Christineother0

Our CFMS Coverage

We haven't published any research on CFMS yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate CFMS Report →

Similar Companies